ProPhase Labs Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ProPhase Labs Inc with three other
companies in this sector in the United States:
sales of $22.59 million
Rigel Pharmaceuticals, Inc.
of which 100%
was Contract Revenues), and
Imprimis Pharmaceuticals Incorporated
ProPhase Labs Inc reported sales of $21.01 million
December of 2016.
a very small
increase of 2.0%
versus 2015, when the company's sales were $20.60 million.
Despite this increase, sales are still
below the level achieved in 2014, when ProPhase Labs Inc
reported sales of $22.07 million.